drugset
drugset / Trial / NCT02654509

Safety and Immunogenicity Study of the Eastern Equine Encephalitis (EEE) Vaccine

NCT02654509 ↗

Phase 2 Completed 138 enrolled U.S. Army Medical Research and Development Command
NaSingle-groupOpen-labelPrevention

Summary

This study is being conducted to collect safety and immunogenicity data for the Eastern Equine Encephalitis (EEE) vaccine.

Timeline

Start
2008-06-03
Primary completion
2016-02-16
Completion
2018-03-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Eastern Equine Encephalitis Vaccine, Inactivated, Dried Vaccine 0.1 ml Subcutaneous

Indications

eastern equine encephalitis